Inclusion of Biological Information in Treatment Planning Optimization Dag Rune Olsen
|
|
|
- Rhoda Blair
- 9 years ago
- Views:
Transcription
1 Inclusion of Biological Information in Treatment Planning Optimization Dag Rune Olsen Institute for Cancer Research, Norwegian Radium Hospital, University of Oslo
2 Theragnostics biological conformality Tumors are often spatially and temporally heterogeneous uniform tumor dose vs non-uniform tumor dose? Treatment optimization guided by biological images of the tumor
3 Theragnostics biological conformality The hypothesis is that non-invasive biological imaging may provide the pertinent information to guide the painting or sculpting of the optimal dose distribution. C.C. Ling, Int. J. Radiat. Oncol. Biol. Phys. 47: , 2000.
4 Theragnostics biological conformality Sir William Osler: The principles and practice of Medicine, 1892 If it were not for the great variability among individuals, medicine might as well be a science and not an art
5 Theragnostics Challenge 1: How to obtain relevant and valid biological information applicable to treatment plan optimization?
6 Theragnostics
7 Theragnostics A): Metabolism (FDG) B): proliferation (FLT) C): hypoxia (Cu-ATSM) D): angiogenesis (MMP) Apisarnthanaraxa & Chao, RADIATION RESEARCH 163, 1 25, 2005.
8 Theragnostics Molecular markers and tracers in PET Mechanism of FDG in functional imaging D. Heron, et al. Medical Dosimetry, 31(1):3-11, 2005.
9 Theragnostics Dynamic contrast enhances MRI: Perfusion, oxygenation Diffusion MRI: Cellular integrity, cell death MRSi: metabolism dce-mri
10 dce- MRI & tumor hypoxia Frequency (%) po 2 (mm Hg) probe MR C i ( t ) = K t Ki ( t u ) trans ν e, i i Ca( u )e 0 trans du E PERF K (ml / (g min) ) trans po 2 (mm Hg)
11 dce- MRI & tumor hypoxia po 2, calc 1: > 20 mm Hg 2: 5-20 mm Hg 3: mm Hg Compartmentization 4: < 0.5 mm Hg
12 Optimization Challenge 2: How to utilize the information in dose distribution optimization? Image of a relevant biological parameters Ideal dose map Planned dose map
13 Optimization Dose modifying factor: D i =OER i (p i ) * D ox
14 Optimization Constraint: - maintaining the mean dose to the target volume: - iso-biological effect in each voxel of the target volume: TCP = TCP [ V, ρ, α(oer),β(oer), γ ] volume density radiosensitivity repopulation rate
15 Optimization where f i (d) is the normalized dose distribution for compartment i, and the integration over N i (d)f i (d) yields the expected number of surviving clonogens in the given compartment. The total TCP is given by the product of the probabilities for controlling each compartment and is obtained by integrating the product over a distribution of radiation sensitivities g(α O ):
16 Optimization For a tumour with a non-uniform distribution of radiation sensitivity, the optimal dose distribution for a given mean dose is the distribution which gives a uniform density ρ of surviving clonogens in the tumour:
17 Optimization
18 Optimization Prescribed compartmental doses and calculated TCP for a uniform and nonuniform prescription scheme.
19 Optimization TCP for a non-uniform and a uniform dose distribution of equal mean dose for four cases. TCP for varying numbers of dose prescription compartments for cases 2 and 3.
20 Optimization
21 Dynamics Challenge 3: How to deal with and systematic and random errors, and spatial and temporal changes? Treatment fraction K trans
22 Dynamics A B Systematic and random errors: The effect on the TCP by randomly (A) or systematically (B) assigning voxels to other tumour compartments.
23 Dynamics Fraction 1 Fraction 2 Fraction 3 Fraction 4 Fraction 5 Fraction 7 Fraction 9 Fraction 10 Spatial distribution of po 2 segmented into four compartments, on 16 of the 18 treatment fractions. Fraction 11 Fraction 12 2 Fraction 13 Fraction Fraction 15 Fraction 16 Fraction 17 Fraction 18
24 Dynamics Hypoxic volume fractions (A) and corresponding optimal dose per treatment fraction (B) for different compartments for each of the treatment fractions.
25 Dynamics 40% reoxygenation TCP as a function of dose per fraction to the normoxic compartment for: no reoxygenation ( ) 10% reoxygenation ( ) 20% reoxygenation( ) 30% reoxygenation( ) 40% reoxygenation ( ) no reoxygenation The dose per fraction to the normoxic compartment was kept constant.
26 Dynamics uniforme dose TCP drops with increasing fraction of acute hypoxic cells, and is lowest appying a uniform dose as compared to non-uinform dose. TCP increases with increasing fraction of the chronic hypoxic celles that receive the intended dose
27 Dynamics
28 Multi-parametric optimization Challenge 4: How to deal with multiple parameters/ information?
29 The Pareto principle: for many events, 80% of the effects come from 20% of the causes. Does this apply to radiation oncology optimization? Can we identify the critical 20% component? Wilfried Fritz Pareto
30 Thank you for your attention!
The validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning.
The validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning. KAROLINA KOKUREWICZ S U P E R V I S O R S : D I N O J A R O S Z Y N S K I, G I U S E P P E S C
Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical
Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent
Moving Beyond RECIST
Moving Beyond RECIST Ihab R. Kamel, M.D., Ph.D. [email protected] Associate Professor Clinical Director, MRI Department of Radiology The Johns Hopkins University School of Medicine Outline Standard measures
Real Time MRI guided Focal Laser Ablation Therapy for Prostate Cancer
Real Time MRI guided Focal Laser Ablation Therapy for Prostate Cancer A/Prof Celi Varol and Dr Orit Raz Uro-Oncologist Nepean and Macquarie Hospital Trial at Macquarie University Hospital Ethics board
Daily IGRT with CT-on-Rails Can Safely Reduce Planning Margin for Prostate Cancer: Implication for SBRT
Daily IGRT with CT-on-Rails Can Safely Reduce Planning Margin for Prostate Cancer: Implication for SBRT Wen Li, Andrew Vassil, Lama Mossolly, Qingyang Shang, Ping Xia Department of Radiation Oncology Why
DWI Case Study - QIBA PDF- MRI Technical Committee. What is IMI?
DWI Case Study - QIBA PDF- MRI Technical Committee QIBA Annual Meeting May 21, 2014 What is IMI? The Innovative Medicines Initiative (IMI) is the world s largest biomedical /healthcare public-private initiative
THE DOSIMETRIC EFFECTS OF
THE DOSIMETRIC EFFECTS OF OPTIMIZATION TECHNIQUES IN IMRT/IGRT PLANNING 1 Multiple PTV Head and Neck Treatment Planning, Contouring, Data, Tips, Optimization Techniques, and algorithms AAMD 2013, San Antonio,
Current and Future Trends in Proton Treatment of Prostate Cancer
Current and Future Trends in Proton Treatment of Prostate Cancer Reinhard W. Schulte Assistant Professor Department of Radiation Medicine Loma Linda University Medical Center Loma Linda, CA, USA Outline
QUANTITATIVE IMAGING IN MULTICENTER CLINICAL TRIALS: PET
Centers for Quantitative Imaging Excellence (CQIE) LEARNING MODULE QUANTITATIVE IMAGING IN MULTICENTER CLINICAL TRIALS: PET American College of Radiology Clinical Research Center v.1 Centers for Quantitative
Radiation Oncology Nursing Care. Helen Lusby Radiation Oncology Nurse BAROC 2012
Radiation Oncology Nursing Care Helen Lusby Radiation Oncology Nurse BAROC 2012 Definitions Radiation Therapy: Treatment of cancer using x- ray particles that cause ionisation within the cells. External
Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward
Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward 33 rd Annual Internal Medicine Update December 5, 2015 Ryan C. Hedgepeth, MD, MS Chief of
Robert Bristow MD PhD FRCPC
Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research
Qualitative Dosimetric and Radiobiological Evaluation of High Dose Rate Interstitial brachytherapy Implants
Int. J. Med. Sci. 2008, 5 41 Research Paper International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2008 5(1):41-49 Ivyspring International Publisher. All rights reserved Qualitative Dosimetric
CYBERKNIFE RADIOSURGERY FOR EARLY PROSTATE CANCER Rationale and Results. Alan Katz MD JD Flushing, NY USA
CYBERKNIFE RADIOSURGERY FOR EARLY PROSTATE CANCER Rationale and Results Alan Katz MD JD Flushing, NY USA Prostate Ablative Therapy Over the last 10 years our therapy has improved bned rates for LDR/HDR
Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience. Richard Pötter MD. BrachyNext, Miami, 2014.
Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience Richard Pötter MD BrachyNext, Miami, 2014 Disclosures Richard Pötter, MD, does not have any financial relationships or
HERC Coverage Guidance Advanced Imaging for Staging of Prostate Cancer Disposition of Public Comments
Table of Contents Commenters... 1 Public Comments... 2 References Provided by Commenters... 6 Commenters Identification Stakeholder A Medical Imaging & Technology Alliance (MITA), Arlington, VA [Submitted
Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate
Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_the_prostate
TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software.
SAMPLE CLINICAL RESEARCH APPLICATION ABSTRACT: TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software. Hypothesis:
Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors. 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D.
Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D., FACS Learning Objectives After reading and reviewing this
Comparison of Threshold-Based Segmentation Methods on Pre- and Post- Therapy PET Scans
M. Phillips, S.F. Barrington, D.L.G. Hill, P.K. Marsden 1 Comparison of Threshold-Based Segmentation Methods on Pre- and Post- Therapy PET Scans Michael Phillips 1 [email protected] Sally F.
Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method
Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method Christopher Martel, M.Sc., CHP Lisa Thornhill,, NRRPT, RT(NM) Boston University Medical Center Thyroid Carcinoma New cases and deaths in
Brain Tumor Treatment
Scan for mobile link. Brain Tumor Treatment Brain Tumors Overview A brain tumor is a group of abnormal cells that grows in or around the brain. Tumors can directly destroy healthy brain cells. They can
Department of BioScience Technology Chung Yuan Christian University 2015/08/13
Department of BioScience Technology Chung Yuan Christian University 2015/08/13 Cancer Cells Cancer, the 1st leading cause of death, is an example of a disease that arises from abnormalities in cell function
In room Magnetic Resonance Imaging guided Radiotherapy (MRIgRT( MRIgRT) Jan Lagendijk and Bas Raaymakers
In room Magnetic Resonance Imaging guided Radiotherapy (MRIgRT( MRIgRT) Jan Lagendijk and Bas Raaymakers : Chris Bakker Boxue Liu Alexander Raaijmakers Rajko Topolnjak Richard van de Put Uulke van der
Radiotherapy in locally advanced & metastatic NSC lung cancer
Radiotherapy in locally advanced & metastatic NSC lung cancer Dr Raj Hegde. MD. FRANZCR Consultant Radiation Oncologist. William Buckland Radiotherapy Centre. Latrobe Regional Hospital. Locally advanced
Immuno-Oncology Model Application in the Preclinical Treatment Setting
Immuno-Oncology Model Application in the Preclinical Treatment Setting Maryland Franklin, Ph.D. Senior Director, Scientific Development [email protected] July 22, 2015 Tumor Models Conference
Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs. Case Study. Surgery. Lumpectomy and Radiation
Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs Michael Alvarado, MD Associate Professor of Surgery University of California San Francisco Case Study 59 yo woman with new palpable
$ $; #! $ $ $ $. $ $, $ $,! $ # $ -$.! #,! # #. ' () «-,» ( ),. 2-3!!!, - $# (RF) #! $., - #! $ $, #. - & # $!.
& :!!" $%&', 15701 ' 7274548, fax: 7274742 e-mail: lmargar@bioluoagr http://kyttarikibioluoagr () %& *&!+ $ ',-" () (),, ( 310 11 Hz ),,!!! ", $! " (! 810 14 Hz! $,,, %, ), & &, ( ), $,!!!! $ $ &, ( mcurie),!!
Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment.
Dictionary Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment. Applicator A device used to hold a radioactive source
Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015
Adjuvant Therapy Non Small Cell Lung Cancer Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 No Disclosures Number of studies Studies Per Month 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3
A new score predicting the survival of patients with spinal cord compression from myeloma
A new score predicting the survival of patients with spinal cord compression from myeloma (1) Sarah Douglas, Department of Radiation Oncology, University of Lubeck, Germany; [email protected] (2) Steven
Monitoring Patient Radiation Dose in VA. Charles M. Anderson MD, PhD Chief Consultant for Diagnostic Services Veterans Health Administration
Monitoring Patient Radiation Dose in VA Charles M. Anderson MD, PhD Chief Consultant for Diagnostic Services Veterans Health Administration TWENTY ONE/NOVEMBER 2011 Computed Tomography (CT), Magnetic Resonance
MATHEMATICAL MODELS OF TUMOR GROWTH INHIBITION IN XENOGRAFT MICE AFTER ADMINISTRATION OF ANTICANCER AGENTS GIVEN IN COMBINATION
MATHEMATICAL MODELS OF TUMOR GROWTH INHIBITION IN XENOGRAFT MICE AFTER ADMINISTRATION OF ANTICANCER AGENTS GIVEN IN COMBINATION Nadia Terranova UNIVERSITÀ DI PAVIA New model development: course of action
FACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
Saturation Biopsy vs. 3D Spatial Biopsy vs. Free Hand Ultrasound biopsy for Targeted Prostate Cancer Therapies
Saturation Biopsy vs. 3D Spatial Biopsy vs. Free Hand Ultrasound biopsy for Targeted Prostate Cancer Therapies John F. Ward, MD Assistant Professor University of Texas M. D. Anderson Cancer Center Ablation
Proton Therapy for Prostate Cancer
Proton Therapy for Prostate Cancer Andrew K. Lee, MD, MPH Director, Proton Therapy Center Associate Professor Department of Radiation Oncology M.D. Anderson Cancer Center Randomized studies showing benefit
COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER
COMMISSIONING for ULTRA-RADICAL SURGERY in ADVANCED OVARIAN CANCER WHY THIS MUST HAPPEN PERSPECTIVE COMMISSIONING FOR WHO, FOR WHAT? Biological Basis Surgical Basis International and national standards
Medical Applications of radiation physics. Riccardo Faccini Universita di Roma La Sapienza
Medical Applications of radiation physics Riccardo Faccini Universita di Roma La Sapienza Outlook Introduction to radiation which one? how does it interact with matter? how is it generated? Diagnostics
P4 Distribution of Cetuximab in Models of Human Lung Cancer
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, Robert Bosch Foundation Stuttgart, Germany FORSYS Partner Project Predictive Cancer Therapy Project Meeting 14.10.09
Focal therapy for prostate cancer: seriously or seriously? Disclosures
Focal therapy for prostate cancer: seriously or seriously? Mitchell Kamrava, MD Assistant Clinical Professor Department of Radiation Oncology University of California Los Angeles Disclosures Speaking honorarium
Frequency of NHL Subtypes in Adults
Chemotherapy Options Stephanie A. Gregory, M.D. The Elodia Kehm Professor of Medicine Director, Section of Hematology Rush University Medical Center Chicago, Illinois Frequency of NHL Subtypes in Adults
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,
Ventilation Perfusion Relationships
Ventilation Perfusion Relationships VENTILATION PERFUSION RATIO Ideally, each alveolus in the lungs would receive the same amount of ventilation and pulmonary capillary blood flow (perfusion). In reality,
Medical Physics and Radioactivity
Medical Physics and Radioactivity Radioactivity Unstable nucleus Electromagnetic wave particle Atoms which emit electromagnetic radiation or a particle by the spontaneous transformation of their nucleus
Future Directions in Cancer Research What does is mean for medical physicists and AAPM?
Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman
HER2 Status: What is the Difference Between Breast and Gastric Cancer?
Ask the Experts HER2 Status: What is the Difference Between Breast and Gastric Cancer? Bharat Jasani MBChB, PhD, FRCPath Marco Novelli MBChB, PhD, FRCPath Josef Rüschoff, MD Robert Y. Osamura, MD, FIAC
Introduction to the Monte Carlo method
Some history Simple applications Radiation transport modelling Flux and Dose calculations Variance reduction Easy Monte Carlo Pioneers of the Monte Carlo Simulation Method: Stanisław Ulam (1909 1984) Stanislaw
Disclosures for Elena Zamagni
Prognostic relevance of 18F-FDG PET/CT in newly diagnosed multiple myeloma patients receiving upfront autologous stem-cell transplantation: a prospective study Zamagni E. 1, Nanni C. 2, Patriarca F. 3,
[Image removed due to copyright concerns]
Radiation Chemistry Ionizing radiation produces abundant secondary electrons that rapidly slow down (thermalize) to energies below 7.4 ev, the threshold to produce electronic transitions in liquid water.
James F. Kravec, M.D., F.A.C.P
James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice
PET. Can we afford PET-CT. Positron annihilation. PET-CT scanner. PET detection
PET-CT Can we afford PET-CT John Buscombe New technology Combines functional information-pet anatomical information-ct Machine able to perform both studies in single imaging episode PET imaging depends
REVIEW OF EXPOSURE LIMITS AND HEALTH CONCERNS SANTA ANA. Base Station Telecommunication Transmitters UNIFIED SCHOOL DISTRICT
SANTA ANA UNIFIED SCHOOL DISTRICT REVIEW OF EXPOSURE LIMITS AND HEALTH CONCERNS Base Station Telecommunication Transmitters Dr. Karl Rodenbaugh, Senior Scientist SCOPE OF SERVICES Review, Describe, Discuss,
Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi
Cancer SBL101 James Gomes School of Biological Sciences Indian Institute of Technology Delhi All Figures in this Lecture are taken from 1. Molecular biology of the cell / Bruce Alberts et al., 5th ed.
BEYOND 18 F-FDG: INTRODUCTION TO NEW RADIOPHARMACEUTICALS
BEYOND F-FDG: INTRODUCTION TO NEW RADIOPHARMACEUTICALS Asti Mattia Nuclear Medicine Department Santa Maria Nuova Hospital, Reggio Emilia, Italy SUMMARY: F-Labelled Choline analogues. Comparison between
PET/CT-MRI First clinical experience
20 th April 2013, Barcelona, Sp PET/CT-MRI First clinical experience Philippe Appenzeller, MD Staff Radiologist and Nuclear Medicine Physician Department Medical Imaging, University Hospital Zurich PET/CT-MR
Failure Modes and Effects Analysis (FMEA)
Failure Modes and Effects Analysis (FMEA) Sasa Mutic Washington University School of Medicine St. Louis Missouri Failure Modes and Effects Analysis Objectives: To motivate the use of FMEA and to provide
Guidelines for pharmacokinetic and pharmacodynamic studies in early phase clinical trials
Guidelines for pharmacokinetic and pharmacodynamic studies in early phase clinical trials Introduction The Pharmacodynamic/ pharmacokinetic Technologies Advisory Committee (PTAC) of Cancer Research UK
Analysis of Set-up Errors during CT-scan, Simulation, and Treatment Process in Breast Cancer Patients
대한방사선종양학회지 2005;23(3):169~175 Analysis of Set-up Errors during CT-scan, Simulation, and Treatment Process in Breast Cancer Patients Department of Radiation Oncology, College of Medicine, Ewha Womans University
Modelling the spread of brain tumours
Snapshots of modern mathematics from Oberwolfach 13/2015 Modelling the spread of brain tumours Amanda Swan Alber t Mur tha The study of mathematical biology attempts to use mathematical models to draw
Obtaining Knowledge. Lecture 7 Methods of Scientific Observation and Analysis in Behavioral Psychology and Neuropsychology.
Lecture 7 Methods of Scientific Observation and Analysis in Behavioral Psychology and Neuropsychology 1.Obtaining Knowledge 1. Correlation 2. Causation 2.Hypothesis Generation & Measures 3.Looking into
Table of Contents. Data Supplement 1: Summary of ASTRO Guideline Statements. Data Supplement 2: Definition of Terms
Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation
GAFCHROMIC DOSIMETRY MEDIA TYPE MD-V3
GAFCHROMIC DOSIMETRY MEDIA TYPE MD-V3 WARNING: Store below 25ºC Store away from radiation sources Do not expose film to sunlight Handle film carefully, creasing may cause damage Do not expose to temperatures
ASCO Initiatives in Personalized Medicine. Richard L. Schilsky, MD, FACP, FASCO Chief Medical Officer American Society of Clinical Oncology
ASCO Initiatives in Personalized Medicine Richard L. Schilsky, MD, FACP, FASCO Chief Medical Officer American Society of Clinical Oncology Financial Disclosures No financial relationships to disclose.
Concurrent Chemotherapy and Radiotherapy for Head and Neck Cancer
Concurrent Chemotherapy and Radiotherapy for Head and Neck Cancer Ryan J. Burri; Nancy Y. Lee Published: 03/23/2009 Abstract and Introduction Abstract Head and neck cancer is best managed in a multidisciplinary
Stomach (Gastric) Cancer. Prof. M K Mahajan ACDT & RC Bathinda
Stomach (Gastric) Cancer Prof. M K Mahajan ACDT & RC Bathinda Gastric Cancer Role of Radiation Layers of the Stomach Mucosa Submucosa Muscularis Serosa Stomach and Regional Lymph Nodes Stomach and Regional
QA of intensity-modulated beams using dynamic MLC log files
36 Original Article QA of intensity-modulated beams using dynamic MLC log files M. Dinesh Kumar, N. Thirumavalavan, D. Venugopal Krishna, M. Babaiah Department of Radiation Oncology, Yashoda Cancer Institute,
Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate e P rofessor Professor Radiation Oncology
Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate Professor Radiation Oncology Disclosure Information I have no financial relationships to disclose relevant to the conten of this presentation.
Peptide receptor radionuclide treatment of neuroendocrine tumours
Peptide receptor radionuclide treatment of neuroendocrine tumours Jann Mortensen Dept. of Clinical Physiology, Nuclear Medicine & PET Neuroendocrine Tumor Center of Excellence Rigshospitalet University
PET/CT in Breast Cancer
PET/CT in Breast Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria Overview Introduction Locorregional
Prostate IMRT: Promises and Problems Chandra Burman, Ph.D. Memorial Sloan-Kettering Cancer Center, New York, NY 10021
Prostate IMRT: Promises and Problems Chandra Burman, Ph.D. Memorial Sloan-Kettering Cancer Center, New York, NY 10021 Introduction Prostate is one of the treatment sites that is well suited for IMRT. For
Endpoint Selection in Phase II Oncology trials
Endpoint Selection in Phase II Oncology trials Anastasia Ivanova Department of Biostatistics UNC at Chapel Hill [email protected] Primary endpoints in Phase II trials Recently looked at journal articles
Advanced Radiation Therapy of Cancer by Proton Beam
March 20th, 2014 Advanced Radiation Therapy of Cancer by Proton Beam Fukui Prefectural Hospital Proton Therapy Center Yamamoto, Kazutaka Wave (electromagnetic wave) IR (Ionizing) Radiation 700 400 350~100
Estimated GFR Based on Creatinine and Cystatin C
Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,
IBA Proton Therapy. Biomed days 2015. Vincent Bossier. System Architect [email protected]. Protect, Enhance and Save Lives
Vincent Bossier System Architect [email protected] IBA Proton Therapy Biomed days 2015 Protect, Enhance and Save Lives 1 Agenda AN INTRODUCTION TO IBA WHY PROTON THERAPY CLINICAL WORKFLOW TREATMENT
MINIMALLY INVASIVE THERMAL THERAPY FOR CANCER TREATMENT BY USING THIN COAXIAL ANTENNAS
MINIMALLY INVASIVE THERMAL THERAPY FOR CANCER TREATMENT BY USING THIN COAXIAL ANTENNAS K. Ito 1, K. Saito 1, T. Taniguchi 2, S. Okabe 2, and H. Yoshimura 1 1 Faculty of Engineering, Chiba University, Chiba,
Dosimetry on the Intraoperative Procedure
LDR-Brachytherapy of Prostate Cancer: Impact of Post-Implant Dosimetry on the Intraoperative Procedure Dr. med. Armin Thöni Dr. phil. nat. Hans Neuenschwander PD Dr. med. Jörn Wulf Radio-Onkologie, Lindenhofspital
THE ANSI/IEEE RF SAFETY STANDARD AND ITS RATIONALE. Om P. Gandhi and Gianluca Lazzi Department of Electrical Engineering Salt Lake City, Utah 84112
Introduction THE ANSI/IEEE RF SAFETY STANDARD AND ITS RATIONALE Om P. Gandhi and Gianluca Lazzi Department of Electrical Engineering Salt Lake City, Utah 84112 In 1960, the American Standards Association
Cell Phone Radiation Effects on Cancer. Tyler Barkich Central Catholic High School Grade 11
Cell Phone Radiation Effects on Cancer Tyler Barkich Central Catholic High School Grade 11 Cancer Overview Cancer cells are cells that grow and divide at an irregular, unregulated pace. Apoptosis does
Goals and Objectives: Breast Cancer Service Department of Radiation Oncology
Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including
1. In the general symbol cleus, which of the three letters. 2. What is the mass number of an alpha particle?
1. In the general symbol cleus, which of the three letters Z A X for a nu represents the atomic number? 2. What is the mass number of an alpha particle? 3. What is the mass number of a beta particle? 4.
Next Generation Small Animal PET Technology
G4 PET/X-ray P R O D U C T N O T E Pre-clinical in vivo Imaging Key Benefits: High performance, ultra-sensitive PET technology designed for pre-clinical imaging 3D PET and X-ray whole body images Purpose
MEDICAL DOSIMETRY. COLLEGE OF APPLIED SCIENCES AND ARTS Graduate Faculty: therapy.
Graduate Catalog 2012-2013 Medical Dosimetry / 339 MEDICAL DOSIMETRY COLLEGE OF APPLIED SCIENCES AND ARTS Graduate Faculty: Collins, Kevin Scott, Associate Professor, Ph.D., Jensen, Steve, Emeritus Professor,
Functional MRI for tumor delineation in prostate radiation therapy
REVIEW For reprint orders, please contact: [email protected] Functional MRI for tumor delineation in prostate radiation therapy A unique property of radiation therapy is the capacity for a differential
